CD8A and neoplasm: To evaluate specific recognition of tumor antigens by CD8+ T cells, we assessed whether tumor reactive memory T cells from mice can react against defined HPV 16 peptides, E711-20 peptide (YMLDLQPETT) and E786-93 peptide (TLGIVCPI).